Ustekinumab for refractory paediatric Crohn's disease: experience from two UK tertiary referral centres

被引:0
|
作者
Rao, R. [1 ]
Gadhok, R. [1 ]
Whitley, L. [2 ]
Burgess, N. [1 ]
Amon, P. [1 ]
Naik, S. [1 ]
Lindsay, J. [1 ]
McCartney, S. [2 ]
Kok, K. [1 ]
机构
[1] Royal London Hosp, Gastroenterol, London, England
[2] Univ Coll London Hosp, Gastroenterol, London, England
来源
关键词
D O I
10.1093/ecco-jcc/jjy222.740
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P616
引用
下载
收藏
页码:S424 / S425
页数:3
相关论文
共 50 条
  • [1] USTEKINUMAB FOR REFRACTORY CROHN'S DISEASE (CD) IN ADOLESCENTS: EXPERIENCE FROM TWO UK IBD CENTRES
    Gadhok, Radha
    Rao, Rohit
    Harpham-Lockyer, Louis
    Kwok, Hanson
    Whitley, Lisa
    Ibarra, Ana
    Burgess, Natasha
    McCartney, Sara
    Kok, Klaartje
    GUT, 2019, 68 : A75 - A75
  • [2] Effectiveness of ustekinumab in refractory Crohn's disease: A real-life experience in a tertiary referral centre
    Truyens, M.
    Geldof, J.
    Dewitte, G.
    Glorieus, E.
    Hindryckx, P.
    Ortega, T. Lobaton
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S330 - S330
  • [3] VEDOLIZUMAB FOR REFRACTORY CROHN'S DISEASE (CD) IN ADOLESCENTS: EXPERIENCE FROM TWO UK IBD CENTRES
    Rao, Rohit
    Gadhok, Radha
    Whitley, Lisa
    Ibarra, Ana
    Evans, Jonathan
    La Lee, Hee
    Kok, Klaartje
    McCartney, Sara
    GUT, 2019, 68 : A68 - A69
  • [4] The use of adalimumab in refractory Crohn's disease: A tertiary referral centre experience
    Ho, G.
    Smith, L.
    Aitken, S.
    Rose, J.
    Ruddell, B.
    Bramley, P.
    Palmer, K.
    Arnott, I.
    Shand, A.
    Satsangi, J.
    GUT, 2007, 56 : A1 - A1
  • [5] Ustekinumab in Treatment of Refractory Paediatric Crohn Disease
    Cameron, F. L.
    Garrick, V.
    Russell, R. K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (03): : E30 - E30
  • [6] Ustekinumab in Crohn's disease: experience from a single tertiary centre
    Kiat, C.
    Stanley, E.
    Bailey, Y.
    Breslin, N.
    McNamara, D.
    Ryan, B.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S245 - S245
  • [7] CLINICAL OUTCOMES OF USTEKINUMAB IN RESISTANT CROHN'S DISEASE: UK IBD TERTIARY REFERRAL CENTRE 'REAL-WORLD' EXPERIENCE
    Borg-Bartolo, Simon Peter
    Kemp, Karen
    Willert, Robert P.
    Makin, Alistair J.
    Levison, Scott Edward
    GUT, 2018, 67 : A71 - A72
  • [8] Ustekinumab in resistant Crohn's disease: 1-year UK IBD tertiary referral centre 'real-world' experience
    Borg-Bartolo, S. P.
    Kemp, K.
    Willert, R. P.
    Makin, A. J.
    Levison, S. E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S464 - S465
  • [9] Ustekinumab use in Crohn's disease: a tertiary centre experience
    Greenup, A.
    Rosenfeld, G.
    Bressler, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S384 - S385
  • [10] Ustekinumab in Crohn's Disease: A Single Tertiary Centre's Experience
    Murphy, E.
    Chan, G.
    Mullen, A.
    Leyden, J.
    MacMathuna, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S275 - S276